Business Context and Reporting Period
This Form 8-K was filed by LeMaitre Vascular, Inc. on April 26, 2022, with the earliest event reported on that date. The filing primarily addresses a strategic decision to close a manufacturing facility and references preliminary financial results for the quarter ended March 31, 2022, which were issued via press release on April 28, 2022.
Key Financial Metrics and Material Changes
The filing details a material change involving the closure of the Company's St. Etienne, France factory, scheduled to halt production and close by June 30, 2022. This action is intended to streamline manufacturing operations and reduce expenses.
- Total Special Charges: Approximately $3.2 million.
- Employment Termination Expenses: Approximately $2.7 million (all cash expenditures).
- Asset Impairment Expenses: Approximately $0.5 million (covering fixed assets, inventory, and intangible assets).
- Timing of Charges: The Company expects to record $3.1 million of these charges in 2022.
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the quarter ended March 31, 2022, as these figures are contained in the referenced press release (Exhibit 99.1) rather than the body of this 8-K.
Guidance, Outlook, and Risks
Management has committed to the factory closure plan to reduce expenses. The filing includes a standard disclaimer regarding forward-looking statements, noting that actual results may differ due to risks and uncertainties detailed in the Company's most recent Form 10-K. The Company undertakes no obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the full preliminary financial results for the quarter ended March 31, 2022, in the press release (Exhibit 99.1).
- Confirm the final timing of the St. Etienne factory closure and the exact date production halts.
- Monitor the actual cash outflow for the $2.7 million in employment termination expenses.
- Review the Company's most recent Form 10-K for detailed risk factors associated with manufacturing consolidation.